Siller, S., Lauseker, M., Karschnia, P., Niyazi, M., Eigenbrod, S., Giese, A., & Tonn, J. (2021). The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents. Acta Neuropathol Commun.
Chicago Style CitationSiller, Sebastian, Michael Lauseker, Philipp Karschnia, Maximilian Niyazi, Sabina Eigenbrod, Armin Giese, i Joerg-Christian Tonn. "The Number of Methylated CpG Sites Within the MGMT Promoter Region Linearly Correlates With Outcome in Glioblastoma Receiving Alkylating Agents." Acta Neuropathol Commun 2021.
Cita MLASiller, Sebastian, et al. "The Number of Methylated CpG Sites Within the MGMT Promoter Region Linearly Correlates With Outcome in Glioblastoma Receiving Alkylating Agents." Acta Neuropathol Commun 2021.